The antiinfective medicine market in the UK has shown a steady increase from 2013 through 2023, with sales reaching 3.04 billion pounds Sterling in 2023. Analyzing the year-on-year data, there's a noticeable peak in growth between 2015 and 2017, followed by a slowdown. The market experienced a dip in 2022 but rebounded slightly in 2023 with a 2.55% increase. Over the last five years, the Compound Annual Growth Rate (CAGR) stands at 2.7%.

Forecasting future sales, the market is expected to grow more modestly from 2024 onwards, with a projected CAGR of 1.69% over the next five years, amounting to an overall growth rate of 8.75% by 2028.

Future trends to watch for:

Potential impact of new drug approvals and innovations in the antiinfective sector.
Changes in healthcare policies and potential effects of antibiotic resistance.
Market adjustments due to global health crises and emerging infections.